BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32421785)

  • 1. Prognostic Value of Masked Uncontrolled Hypertension Defined by Different Ambulatory Blood Pressure Criteria.
    Coccina F; Pierdomenico AM; Cuccurullo C; Pizzicannella J; Madonna R; Trubiani O; Cipollone F; Pierdomenico SD
    Am J Hypertens; 2020 Aug; 33(8):726-733. PubMed ID: 32421785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients.
    Pierdomenico SD; Pierdomenico AM; Coccina F; Porreca E
    Am J Hypertens; 2017 Nov; 30(11):1106-1111. PubMed ID: 29059303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring.
    Coccina F; Pierdomenico AM; Cuccurullo C; Pizzicannella J; Guagnano MT; Renda G; Trubiani O; Cipollone F; Pierdomenico SD
    J Clin Hypertens (Greenwich); 2022 May; 24(5):591-597. PubMed ID: 35301793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K
    JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Masked Hypertension and Cardiovascular Disease Events in a Prospective Cohort of Blacks: The Jackson Heart Study.
    Booth JN; Diaz KM; Seals SR; Sims M; Ravenell J; Muntner P; Shimbo D
    Hypertension; 2016 Aug; 68(2):501-10. PubMed ID: 27354424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
    Naser N; Dzubur A; Durak A; Kulic M; Naser N
    Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Event Risks Associated With Masked Nocturnal Hypertension Defined by Home Blood Pressure Monitoring in the J-HOP Nocturnal Blood Pressure Study.
    Fujiwara T; Hoshide S; Kanegae H; Kario K
    Hypertension; 2020 Jul; 76(1):259-266. PubMed ID: 32520613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension.
    Coccina F; Pierdomenico AM; De Rosa M; Lorenzo B; Foglietta M; Petrilli I; Vitulli P; Pizzicannella J; Trubiani O; Cipollone F; Renda G; Pierdomenico SD
    Am J Hypertens; 2021 May; 34(5):504-510. PubMed ID: 33186441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative meta-analysis of prospective observational studies on masked hypertension and masked uncontrolled hypertension defined by ambulatory and home blood pressure.
    Zhang DY; Guo QH; An DW; Li Y; Wang JG
    J Hypertens; 2019 Sep; 37(9):1775-1785. PubMed ID: 31219948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Nondipping and Morning Surge in Elderly Treated Hypertensive Patients With Controlled Ambulatory Blood Pressure.
    Pierdomenico SD; Pierdomenico AM; Coccina F; Lapenna D; Porreca E
    Am J Hypertens; 2017 Feb; 30(2):159-165. PubMed ID: 27838624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.
    Ravenell J; Shimbo D; Booth JN; Sarpong DF; Agyemang C; Beatty Moody DL; Abdalla M; Spruill TM; Shallcross AJ; Bress AP; Muntner P; Ogedegbe G
    Circulation; 2017 Jun; 135(25):2470-2480. PubMed ID: 28428231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence.
    Siddiqui M; Judd EK; Dudenbostel T; Zhang B; Gupta P; Tomaszewski M; Patel P; Oparil S; Calhoun DA
    Hypertension; 2019 Sep; 74(3):652-659. PubMed ID: 31327263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Rahman M; Wang X; Bundy JD; Charleston J; Cohen D; Cohen J; Drawz PE; Ghazi L; Horowitz E; Lash JP; Schrauben S; Weir MR; Xie D; Townsend RR;
    J Am Soc Nephrol; 2020 Nov; 31(11):2609-2621. PubMed ID: 32973085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Masked Uncontrolled Hypertension in CKD.
    Agarwal R; Pappas MK; Sinha AD
    J Am Soc Nephrol; 2016 Mar; 27(3):924-32. PubMed ID: 26163421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study.
    Ghazi L; Cohen LP; Muntner P; Shimbo D; Drawz PE
    Hypertension; 2020 Oct; 76(4):1090-1096. PubMed ID: 32829666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosing Masked Hypertension Using Ambulatory Blood Pressure Monitoring, Home Blood Pressure Monitoring, or Both?
    Anstey DE; Muntner P; Bello NA; Pugliese DN; Yano Y; Kronish IM; Reynolds K; Schwartz JE; Shimbo D
    Hypertension; 2018 Nov; 72(5):1200-1207. PubMed ID: 30354812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Out-of-Clinic Sympathetic Activity Is Increased in Patients With Masked Uncontrolled Hypertension.
    Siddiqui M; Judd EK; Jaeger BC; Bhatt H; Dudenbostel T; Zhang B; Edwards LJ; Oparil S; Calhoun DA
    Hypertension; 2019 Jan; 73(1):132-141. PubMed ID: 30571547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.
    Asayama K; Thijs L; Li Y; Gu YM; Hara A; Liu YP; Zhang Z; Wei FF; Lujambio I; Mena LJ; Boggia J; Hansen TW; Björklund-Bodegård K; Nomura K; Ohkubo T; Jeppesen J; Torp-Pedersen C; Dolan E; Stolarz-Skrzypek K; Malyutina S; Casiglia E; Nikitin Y; Lind L; Luzardo L; Kawecka-Jaszcz K; Sandoya E; Filipovský J; Maestre GE; Wang J; Imai Y; Franklin SS; O'Brien E; Staessen JA;
    Hypertension; 2014 Nov; 64(5):935-42. PubMed ID: 25135185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.